Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir

Molecular Pharmaceutics

Volumn 10, Issue 9, 2013, Pages 3392-3403

  Ilevbare, Grace A ^a   Liu, Haoyu ^b   Pereira, Junia ^b   Edgar, Kevin J ^b   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

6 carboxypullulan ethers; Amorphous solid dispersions; Cellulose carboxyalkanoates; Colloid formation; Liquid liquid phase separation; Nanodroplet formation; Ritonavir; Supersaturation

Indexed keywords

DRUG ADDITIVE; NANOCRYSTAL; RITONAVIR;

AQUEOUS SOLUTION; ARTICLE; COLLOID; CRYSTALLIZATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; LIQUID LIQUID EXTRACTION; NANOPHARMACEUTICS; PRIORITY JOURNAL;

COLLOIDS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR STRUCTURE; POLYMERS; RITONAVIR; WATER;

EID: 84883573956     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400228x     Document Type: Article

References (44)

1. Yan, M.; Du, J.; Gu, Z.; Liang, M.; Hu, Y.; Zhang, W.; Priceman, S.; Wu, L.; Zhou, Z. H.; Liu, Z.; Segura, T.; Tang, Y.; Lu, Y. A novel intracellular protein delivery platform based on single-protein nanocapsules Nat. Nanotechnol. 2012, 5, 48-53
2. Chen, L. F.; Di, J.; Cao, C.; Zhao, Y.; Ma, Y.; Luo, J.; Wen, Y.; Song, W.; Song, Y.; Jiang, L. A pH-driven DNA nanoswitch for responsive controlled release Chem. Commun. 2011, 47, 2850-2852
3. Martinez, M. N.; Amidon, G. L. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals J. Clin. Pharmacol. 2002, 42, 620-643
4. Löbenberg, R.; Amidon, G. L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards Eur. J. Pharm. Biopharm. 2000, 50, 3-12
5. Li, A. P. Screening for human ADME/Tox drug properties in drug discovery Drug Discovery Today 2001, 6, 357-366
6. Li, A. P. Advancing technologies for accelerated drug development Drug Discovery Today 2003, 8, 200-202
7. Van Eerdenbrugh, B. V.; Vermant, J.; Martens, J. A.; Froyen, L.; Humbeeck, J. V.; Van den Mooter, G.; Augustijns, P. Solubility increases associated with crystalline drug nanoparticles: methodologies and significance Mol. Pharmaceutics 2010, 7, 1858-1870
8. Jia, L.; Wong, J.; Cerna, C.; Weitman, S. D. Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry Pharm. Res. 2002, 19, 1091-1096
9. Lindfors, L.; Skantze, P.; Skantze, U.; Rasmusson, M.; Zackrisson, A.; Olsson, U. Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening Langmuir 2006, 22, 906-910
10. Sigfridsson, K.; Lundqvist, A. J.; Strimfors, M. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development Drug Dev. Ind. Pharm. 2009, 35, 1479-1486
11. Morgen, M.; Bloom, C.; Beyerinck, R.; Bello, A.; Song, W.; Wilkinson, K.; Steenwyk, R.; Shamblin, S. Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of low-solubility, high-permeability drug Pharm. Res. 2012, 29, 427-440
12. Kim, K.; Lee, L. S.; Centrone, A.; Hatton, T. A.; Myerson, A. S. Formation of nanosized organic molecular crystals on engineered surfaces J. Am. Chem. Soc. 2009, 131, 18212-18213
13. Brick, M. C.; Palmer, H. J.; Whitesides, T. H. Formation of colloidal dispersions of organic materials in aqueous media by solvent shifting Langmuir 2003, 19, 6367-6380
14. Douroumis, D.; Fahr, A. Stable carbamazepine colloidal systems using the cosolvent technique Eur. J. Pharm. Sci. 2007, 30, 367-374
15. Moribe, K.; Pongpeerapat, A.; Tozuka, Y.; Yamamoto, K. Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures Pharmazie 2006, 61, 97-101
16. Aisha, A. F. A.; Ismail, Z.; Abu-Salah, K. M.; Majid, A. M. S. A. Solid dispersions of α-Mangostin Improve its aqueous solubility through self-assembly of nanomicelles J. Pharm. Sci. 2011, 1-11
17. Tachibana, T.; Nakamura, A. A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: Dispersion of β-carotene by polyvinylprrolidone Kolloid Z. Z. Polym. 1965, 203, 130-133
18. Frank, K. J.; Westedt, U.; Rosenblatt, K. M.; Hölig, P.; Rosenber, J.; Mägerlein, M.; Fricker, G.; Brand, M. The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: Impact on solubility Int. J. Nanomed. 2012, 7, 5757-5768
19. Serajuddin, A. T. M. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 1999, 10, 1058-1066
20. Alonzo, D. E.; Gao, Y.; Zhou, D.; Mo, H.; Zhang, G. G. Z.; Taylor, L. S. Dissolution and Precipitation Behavior of Amorphous Solid Dispersions J. Pharm. Sci. 2011, 100, 3316-3331
21. Law, D.; Krill, S. L.; Schmitt, E. A.; Fort, J. J.; Qiu, Y.; Wang, W.; Porter, W. R. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions J. Pharm. Sci. 2001, 90, 1015-1025
22. Law, D.; Schmitt, E. A.; Marsh, K. C.; Everitt, E. A.; Wang, W.; Fort, J. J.; Krill, S. L.; Qiu, Y. Ritonavir-PEG 8000 amorphous solid dispersions: In vitro and in vivo evaluations J. Pharm. Sci. 2004, 93, 563-570
23. Frenkel, Y. V.; Clark, A. D.; Das, K.; Wang, Y.-H.; Lewi, P. J.; Janssen, P. A. J.; Arnold, E. Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability J. Med. Chem. 2005, 48, 1974-1983
24. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Effect of binary additive combinations on solution crystal growth of the poorly-water soluble drug, ritonavir Cryst. Growth Des. 2012, 12, 6050-6060
25. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Understanding polymer properties important for crystal growth inhibition-Impact of chemically diverse polymers on solution crystal growth of ritonavir Cryst. Growth Des. 2012, 12, 3133-3143
26. Ilevbare, G. A.; Liu, H.; Edgar, K. J.; Taylor, L. S. Maintaining Supersaturation in Aqueous Drug Solutions-Impact of Different Polymers on Induction Times Cryst. Growth Des. 2013, 13, 740-751
27. Liu, H.; Ilevbare, G. A.; Cherniawski, B. P.; Ritchie, E. T.; Taylor, L. S.; Edgar, K. J. Synthesis and Preliminary Structure-Property Evaluation of Cellulose ω-Carboxyesters for Amorphous Solid Dispersions Carbohydr. Polym. 2012, 10.1016/j.carbpol.2012.11.049
28. Pereira, J. M.; Mahoney, M.; Edgar, K. J. Synthesis of amphiphilic 6-carboxypullulan ethers Carbohydr. Polym. 2012, 10.1016/j.carbpol.2012.12.029
29. Ilevbare, G. A.; Taylor, L. S. Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly-water soluble drugs- Implications for solubility enhancing formulations Cryst. Growth Des. 2013, 13, 1497-1509
30. Ananthapadmanabhan, K. P.; Goddard, E. D.; Turro, N. J.; Kuo, P. L. Fluorescence probes for critical micelle concentration Langmuir 1985, 1, 352-355
31. Zhao, C.-L.; Winnik, M. A. Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers Langmuir 1990, 6, 514-516
32. Coan, K. E. D.; Shoichet, B. K. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors J. Am. Chem. Soc. 2008, 130, 9606-9612
33. Coan, K. E. D.; Maltby, D. A.; Burlingame, A. L.; Shoichet, B. K. Promiscuous aggregate-based inhibitors promote enzyme unfolding J. Med. Chem. 2009, 52, 2067-2075
34. Andronis, V.; Yoshioka, M.; Zografi, G. Effects of sorbed water on the crystallization of indomethacin from the amorphous state J. Pharm. Sci. 1997, 86, 346-351
35. Baird, J. A.; Van Eerdenbrugh, B.; Taylor, L. S. A classification system to assess the crystallization tendency of organic molecules from undercooled melts J. Pharm. Sci. 2010, 99, 3787-3806
36. Davey, R. J.; Hilton, A. M.; Garside, J.; de la Fuente, M.; Edmondson, M.; Rainsford, P. Crystallisation of oil-in-water emulsions. Amphiphile directed nucleation in aqueous emulsions of m-chloronitrobenzene J. Chem. Soc., Faraday Trans. 1996, 92, 1927-1933
37. Feng, B. Y.; Simeonov, A.; Jadhav, A.; Babaoglu, K.; Inglese, J.; Shoichet, B. K.; Austin, C. P. A high-throughput screen for aggregation-based inhibition in a large compound library J. Med. Chem. 2007, 50, 2385-2390
38. Friesen, D. T.; Shanker, R.; Crew, M.; Smithey, D. T.; Curatolo, W. J.; Nightingale, J. A. S. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: An overview Mol. Pharmaceutics 2008, 5, 1003-1019
39. Hsieh, Y.; Ilevbare, G. A.; Van Eerdenbrugh, B.; Box, K.; Sanchez-Felix, M.; Taylor, L. S. pH-induced precipitation behavior of weakly basic compounds: Determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties Pharm. Res. 2012, 20, 2738-2753
40. McGovern, S. L.; Caselli, E.; Grigorieff, N.; Shoichet, B. K. A Common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J. Med. Chem. 2002, 45, 1712-22
41. Shoichet, B. K. Interpreting Steep Dose-Response Curves in Early Inhibitor Discovery J. Med. Chem. 2006, 49, 7274-7277
42. Feng, B. Y.; Shelat, A.; Doman, T. N.; Guy, R. K.; Shoichet, B. K. High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 2005, 3, 146-148
43. Amis, E. J.; Hu, N.; Seery, T. A. P.; Hogen-Esch, T. E.; Yassini, M.; Hwang, F. Associating polymers containing fluorocarbon hydrophobic units. In Hydrophilic polymers; Advances in Chemistry, Vol. 248; American Chemical Society: Washington, DC, 1996; pp 279-302.
44. Mullin, J. W. Crystallization, 4 th ed.; Elsevier Butterworth-Heinemann: Oxford, 2001.